Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02800512 · ClinicalTrials.gov registry record · NA
SCP vs HUSLS for Pelvic Organ Prolapse Repair
A NA study of Pelvic Organ Prolapse and Cystocele, sponsored by Loma Linda University.
- Active
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT02800512 is a NA study of Pelvic Organ Prolapse and Cystocele that is active but no longer recruiting, run by Loma Linda University. The registered enrollment target is 112 participants, below the 142-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02800512, a NA study of Pelvic Organ Prolapse and Cystocele, is active but no longer recruiting, sponsored by Loma Linda University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of R-SCP versus HUSLS for treatment of pelvic organ prolapse.
Conditions Studied
Interventions
- PROCEDURE Robotic sacrocolpopexy
- PROCEDURE high uterosacral ligament suspension
Study Locations (1)
California
- Loma Linda University URO/GYN - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2016-12 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02800512
The ClinicalTrials.gov registry entry for NCT02800512 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (21% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Robotic sacrocolpopexy is the first listed.
NCT02800512 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02800512 about?
NCT02800512 is a clinical study titled "SCP vs HUSLS for Pelvic Organ Prolapse Repair". The purpose of this study is to compare the effectiveness of R-SCP versus HUSLS for treatment of pelvic organ prolapse.
What is the current status of trial NCT02800512?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2016-12. Estimated completion is 2025-12.
What conditions does trial NCT02800512 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse, Cystocele, Rectocele, Enterocele.
What interventions are being tested in trial NCT02800512?
The interventions under investigation include: Robotic sacrocolpopexy (PROCEDURE), high uterosacral ligament suspension (PROCEDURE).
Who is sponsoring clinical trial NCT02800512?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02800512 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
-
The AccelERate Trial
RECRUITING · NA
-
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.